SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
<h4>Background</h4> Most of the studies that have informed the public health response to the COVID-19 pandemic in Kenya have relied on samples that are not representative of the general population. We conducted population-based serosurveys at three Health and Demographic Surveillance Sys...
Saved in:
Similar Items
-
SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.
by: Anthony O Etyang, et al.
Published: (2022) -
Health Reforms in Pursuit of Universal Health Coverage: Lessons from Kenyan Bureaucrats
by: Wangari Ng'ang'a, et al.
Published: (2024) -
Indirect health effects of the COVID-19 pandemic in Kenya: a mixed methods assessment
by: Edwine Barasa, et al.
Published: (2021) -
Suspected poor-quality medicines in Kenya: a retrospective descriptive study of medicine quality-related complaints reports in Kenya's pharmacovigilance database
by: Anthony Martin Toroitich, et al.
Published: (2024) -
Trypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis.
by: John K Thuita, et al.
Published: (2008)